Hyperprolactinemia is the presence of elevated prolactin levels that occurs in about one-thirds of patients w/ chronic kidney disease & resolves after successful transplantation.
It may cause visual field defects or headache in both men and women.
In women, signs and symptoms include menstrual irregularity, galactorrhea, infertility, vaginal dryness, dyspareunia, loss of libido and reduction in vertebral bone density (in sustained, pronounced hyperprolactinemia).
While in men, signs and symptoms include diminished libido, hypogonadism, gonadotrophin suppression, osteopenia, decreased muscle mass, and decreased facial hair that may occur in prolonged hyperprolactinemia.
Vitamin C supplementation appears to yield significant reductions in glucose concentrations in patients with diabetes, particularly older individuals and those with more prolonged supplementation, according to a study.
Supplementation with omega-3 fatty acids in combination with rosuvastatin may yield significant reductions in triglycerides and nonhigh-density lipoprotein (HDL) cholesterol as compared with rosuvastatin monotherapy, according to data from the ROMANTIC (rosuvastatin-omacor in residual hypertriglyceridemia) trial.
Q: Introduction to perimenopause – when it begins, what are the signs and symptoms?
A: Many women do not realize that menopause does not happen over 24 hours. For a period of 10 to 15 years before menopause is established at the average age of 51, a woman will already be undergoing a period of change in a phase of life known as perimenopause or ‘around menopause’. Perimenopause is typically experienced by women aged between 40 and 56.
Individuals with obesity and high abdominal fat mass appear to have a twofold increased risk of developing psoriasis, as shown in a study. Long-term weight gain of ≥10 kg is also associated with a substantially increased risk.